Sale!

WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 Genetic Test

4,400 د.إ

-21%

The “WDR81 Gene Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 Genetic Test” is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the WDR81 gene. These mutations are linked to a rare genetic disorder characterized by intellectual disability, impaired coordination (cerebellar ataxia), and balance issues (dysequilibrium syndrome type 2). The test, priced at 4400 AED, is crucial for accurate diagnosis, enabling targeted management and therapy plans for affected individuals. Through advanced genetic analysis, DNA Labs UAE offers families and healthcare professionals vital information for understanding and addressing the complex needs associated with this condition.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

WDR81 Gene Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 Genetic Test

Test Name: WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2.

Test Details:

The WDR81 gene is associated with a rare genetic disorder called Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 (CAMRQ2). This disorder is characterized by intellectual disability, developmental delay, cerebellar ataxia (problems with coordination and balance), and dysequilibrium (unsteady gait).

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of CAMRQ2, NGS genetic testing can be used to identify mutations or variations in the WDR81 gene that may be causing the disorder. By analyzing the WDR81 gene, NGS genetic testing can provide information about the specific genetic variant responsible for CAMRQ2. This information can help with the diagnosis of the disorder, as well as provide important insights into its underlying cause and potential treatment options.

Test Name WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2
Test Details

The WDR81 gene is associated with a rare genetic disorder called Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 (CAMRQ2). This disorder is characterized by intellectual disability, developmental delay, cerebellar ataxia (problems with coordination and balance), and dysequilibrium (unsteady gait).

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of CAMRQ2, NGS genetic testing can be used to identify mutations or variations in the WDR81 gene that may be causing the disorder.

By analyzing the WDR81 gene, NGS genetic testing can provide information about the specific genetic variant responsible for CAMRQ2. This information can help with the diagnosis of the disorder, as well as provide important insights into its underlying cause and potential treatment options.